A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder

NCT07252908 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: TQC3721 inhalation powder
DRUG: Placebo for TQC3721 inhalation powder

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.